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Type I interferons (IFNs) are considered to be the
universal mechanism by which viral infections are
controlled. However, many IFN-stimulated genes
(ISGs) rely on antiviral pathways that are toxic to
host cells, which may be detrimental in nonrenew-
able cell types, such as neurons.We show that dorsal
root ganglionic (DRG) neurons produced little type I
IFNs in response to infection with a neurotropic
virus, herpes simplex type 1 (HSV-1). Further, type I
IFN treatment failed to completely block HSV-1 repli-
cation or to induce IFN-primed cell death in neurons.
We found that DRG neurons required autophagy to
limit HSV-1 replication both in vivo and in vitro. In
contrast, mucosal epithelial cells and other mitotic
cells responded robustly to type I IFNs and did not
require autophagy to control viral replication. These
findings reveal a fundamental difference in the innate
antiviral strategies employed by neurons and mitotic
cells to control HSV-1 infection.
INTRODUCTION
Type I interferons (IFNs) play a key role in innate antiviral defense
through the upregulation of numerous ISGs that antagonize viral
replication and activate adaptive immunity (Stetson andMedzhi-
tov, 2006). Type I IFN receptor signaling activates both antiviral
and cell death pathways as key components of host antiviral
defense (Sadler and Williams, 2008). In most tissues, the death
of virally infected cells is a desired mode of virus containment.
Such cell death aids the immune response by preventing further
viral replication and spread, aiding cell recruitment, and priming
adaptive immune responses (Barber, 2001). However, the verte-
brate host cannot tolerate death of neurons as a general strategy
to control virus infection (Danthi et al., 2010; Griffin, 2010;
Khanna et al., 2004; Levine, 2002).
In addition to the interferon response, the autophagy pathway
can play an important role in viral containment (Virgin and Levine,
2009). Autophagy is a highly conserved catabolic pathway crit-
ical in maintaining basal turnover of cellular components and is
a survival mechanism during starvation (Klionsky and Emr,334 Cell Host & Microbe 12, 334–345, September 13, 2012 ª2012 El2000). The autophagy pathway includes several distinct forms
of lysosomal degradation, including macroautophagy, chap-
erone-mediated autophagy, and microautophagy. Macroau-
tophagy (hereafter referred to as autophagy) involves the forma-
tion of double membrane structures termed autophagosomes
that engulf cytoplasmic components including proteins, lipids,
and entire organelles (Levine and Klionsky, 2004; Mizushima
et al., 2008). Mature autophagosomes efficiently fuse with lyso-
somes, resulting in rapid, bulk degradation of engulfed material.
In addition to its roles in cellular recycling and the starvation
response, it is now clear that autophagy is intimately involved
in immune responses of eukaryotic organisms (Deretic and
Levine, 2009). Thus, autophagy has coevolved with the verte-
brate immune system to enhance immune responses while
retaining an evolutionarily ancient, innate pathogen degradation
capacity.
Notably, most of the in vivo evidence for an antiviral role of
autophagy in mammalian hosts is restricted to viruses that
specifically target neurons, including Sindbis virus and herpes
simplex virus type 1 (HSV-1) (Orvedahl and Levine, 2008). Over-
expression of the Atg6 or Beclin-1 protein results in decreased
cell death and increased survival of neonatal mice intracranially
injectedwith Sindbis virus (Liang et al., 1998). Moreover, deletion
of host Atg genes resulted in a failure to clear Sindbis viral
proteins and increased cell death in the absence of autophagy
(Orvedahl et al., 2010). HSV-1 encodes ICP34.5, a virulence
factor necessary for HSV replication in neurons but not other
cell types (Chou et al., 1990; Chou and Roizman, 1992; Whitley
et al., 1993). ICP34.5 antagonizes downstream effects of PKR
by dephosphorylating the transcription factor e-IF2a, thus
enabling viral translation (He et al., 1997). In addition, recent
studies demonstrated that ICP34.5 also contains a domain that
binds to Beclin-1 (Orvedahl et al., 2007). Deletion of the Beclin-
1-binding domain (bbd) of ICP34.5 from HSV-1 effectively abro-
gated autophagy inhibition by the virus, resulting in reduced
viral replication, cell death, and mortality after intracranial infec-
tion (Orvedahl et al., 2007). In contrast, a limited phenotype of
bbd mutant was observed in nonneuronal cell types in vitro
(Alexander et al., 2007; Orvedahl et al., 2007). However, the basis
for the discrepancy between the striking phenotype seen in vivo
versus the lack of effect in cell lines tested in vitro remains
unresolved.
During the course of natural genital HSV infection, HSV
predominantly infects two cell types: rapidly dividing, short-lived
mucosal epithelial cells at the site of infection and the innervatingsevier Inc.
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been historically associated with HSV-2, HSV-1 accounts for at
least half of new cases in developed countries (Gupta et al.,
2007). HSV replication at the primary site of infection can result
in uptake of virions by innervating neurons and subsequent entry
into the peripheral nervous system (PNS) by retrograde axonal
transport, where the virus establishes latency. Here, we utilize
a mouse model of genital infection with HSV-1 to interrogate
the innate immune strategies in different cell types. We employ
a series of host knockouts and viralmutants todissect the relative
contributions of the type I interferon and autophagy pathways in
combatingHSV-1 infection in vitro and in vivo.Our findings reveal
that autophagy, while dispensable in mitotic cells, plays a funda-
mental role in antiviral immunity to HSV-1 in neurons.
RESULTS
HSV Induces Higher Levels of Type I IFNs inMitotic Cells
than in Neurons
To evaluate the innate HSV antiviral pathways in different cell
types, we first sought to evaluate the ability of different HSV-1
target cells to induce type I IFN production upon viral infection.
To this end, we infected neurons, keratinocytes, and mouse
embryonic fibroblasts (MEFs) with various multiplicity of
infections (MOIs) of HSV-1 and examined IFN-a4 and IFN-b
messenger RNA (mRNA) expression by RT-qPCR. As expected,
both IFN-a4 and IFN-b were induced in a time-dependent
manner in MEFs at different MOIs (Figures 1A and 1B). In
contrast, dorsal root ganglion (DRG) neurons failed to induce
significant levels of IFN mRNA at all MOIs tested (Figures 1A
and 1B) and consequently failed to induce expression of the
ISG, Mx-1 (Figure S1A available online). In addition, while a slight
reduction in viral titers at later time points was observed in
infected neurons compared to MEFs (Figure S1B), the near
complete absence of IFN-a4 and IFN-b in the HSV-infected
neurons could not be accounted for by the moderate reduction
in viral titers.
To rule out the possibility that observed differences were due
to viral inhibition of IFNs specifically in neurons, we transfected
these cell types with Poly I:C, a synthetic mimic of a viral path-
ogen associated molecular pattern (PAMP) that activates
MDA5-dependent cytosolic nucleic acid sensing pathway (Gitlin
et al., 2006; Kato et al., 2006). Interestingly, we found that
although significant levels of type I IFNs were induced in all cell
types, the levels were strikingly lower in neurons than in the
mitotic cell types tested (Figures 1C and 1D), despite the fact
that Poly I:C transfection efficiency was comparable between
these cell types (Figure S1C). These data indicate that neurons
are limited in their ability to sense certain viral PAMPs and/or
induce robust IFN gene expression.
Mitotic Cells Are More Responsive to Type I IFN
than Are Neurons
Multiple cell types contribute to type I interferon production
during a viral infection (Stetson and Medzhitov, 2006). To
examine whether neurons and mitotic cells respond equivalently
to exogenous type I IFN treatment, both cell types were
treated with increasing amounts of recombinant IFN-b. Eighteen
hours later, IFN-treated neurons or mitotic counterparts wereCell Host & Mchallenged with HSV-1-GFP, and infected cells were enumer-
ated by flow cytometry. Increasing doses of exogenous IFN-b
dramatically reduced HSV-1 infection in both MEFs and kerati-
nocytes (Figures 2A and 2B). In contrast, the same concentra-
tions of IFN-b provided significantly less protection in neurons
(Figure 2C). In order to confirm that IFN-b pretreatment was
significantly less effective in inducing an anti-HSV-1 state in
neurons than in mitotic cells, we evaluated production of infec-
tious HSV-1 after IFN-b pretreatment. Although increasing doses
of IFN-b significantly reduced viral titer in both MEFs and
neurons, the extent of reduction was significantly greater in
MEFs (Figure S2A). The near complete lack of HSV-1 infection
inMEFs treatedwith 250U/ml of IFN-b is likely due to a combina-
tion of robust antiviral ISG induction and death of infected
MEFs (Figure S2B). Interestingly, infected neurons did not
exhibit significant increase in cell death when treated with high
concentrations of IFN-b. These data indicate that, while IFN-b
induces an antiviral state in both mitotic cells and neurons,
IFN-b confers less antiviral protection against HSV-1 in neurons
than in mitotic cells.
Type I IFN Fails to Prime Neurons for Cell Death
One major mechanism whereby type I IFNs prevent viral
replication is by inducing cell death in infected cells. We specu-
lated that the reduced effectiveness of type I IFN in limiting viral
replication might be due to reduced IFN-triggered cell death in
neurons. As neurons are postmitotic, nonrenewable cells essen-
tial for host survival, reduced responsiveness to type I IFN
observed in neurons might serve to help to minimize neuronal
death and thereby enhance host survival. To directly test cell
type-specific sensitivity to IFN-induced death, we evaluated
cell death in IFN-b-pretreated MEFs and neurons challenged
with Poly I:C. Type I IFN pretreatment of fibroblasts primes
them for execution by apoptosis upon detection of viral replica-
tion intermediates (Esaki et al., 2010). Consistently, we found
that pretreatment with IFN-b profoundly increased cell death in
Poly I:C-transfected MEFs (Figure 3A). We observed a similar
relationship in Poly I:C-transfected keratinocytes (data not
shown), indicating that type I interferon primes cell death upon
detection of viral replication intermediates in mitotic cell types.
In contrast, neurons were completely resistant to the effects of
IFN-b for cell death upon Poly I:C stimulation (Figure 3A). Resis-
tance to cell death was not a general feature of neurons, since
they succumbed to cell death upon induction of apoptosis by
an IFN-independent pathway through staurosporine treatment
(Figure 3B).
Next, we wished to interrogate the mechanism by which
neurons are resistant to both exogenous type I IFN and to IFN-
induced cell death. To this end, neurons and mitotic cells
were stimulated with IFN-b, and ISG mRNA expression levels
were analyzed over a time course. Although neurons were
capable of increasing the expression of ISGs in response to
IFN-b, we observed lower steady state and IFN-induced
mRNA levels of several key effector ISGs involved in host cell
death, such as PKR, in neurons compared to mitotic cells (Fig-
ure S3A). In contrast, we observed comparable levels of
STAT1 and only a minor decrease in IRF-7 levels in neurons
compared to MEFs (Figure S3A). HSV-1 interferes with IFN
signaling at multiple levels (Chee and Roizman, 2004). Thus,icrobe 12, 334–345, September 13, 2012 ª2012 Elsevier Inc. 335
Figure 1. Neurons Are Impaired in Their Capacity to Respond to Viral Stimulation and Induce Type I IFNs
(A and B) Mouse embryonic fibroblasts (MEFs) and neurons were infected with HSV1-GFP at MOIs of 0.1, 1.0, and 10.0. RNA was isolated from all cells at 0, 12,
24, and 54 hr after infection. Relative fold increases in IFN-a4 (A) and IFN-b (B) production were determined by quantitative RT-PCR of isolated RNA relative to the
housekeeping gene hprt.
(C and D) MEFs, keratinocytes, and neurons were transfected with Poly I:C (1.0 mg/ml). RNA was isolated from all cells at the time points indicated, and fold
increases of IFN-a4 (C) and IFN-b (D) relative to hprt were determined by RT-qPCR. Data are representative of three independent experiments.
See also Figure S1.
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treated with IFN-b are differentially regulated in neurons and
MEFs. Our data indicated that HSV-induced decline in ISG
expression was more exaggerated in neurons compared to336 Cell Host & Microbe 12, 334–345, September 13, 2012 ª2012 ElMEFs (Figure S3C). Thus, the type I IFN-induced gene
expression prior to and after HSV-1 infection are significantly
attenuated in neurons and could in part explain their impaired
resistance to HSV-1 infection after IFN treatment.sevier Inc.
Figure 2. Neurons Have Impaired Type I IFN-Dependent Anti-HSV-1 Protection
Primary keratinocytes, MEFs, and neurons were pretreated for 18 hr with the indicated amount of IFN-b. After pretreatment, all cells were infected with 0.5 MOI of
HSV1-GFP. At the time points indicated, cells were isolated and analyzed for GFP expression by flow cytometry. Data are shown as number of infected cells
(GFP+) per 10,000 cell events for MEFs (A), keratinocytes (B), and neurons (C). Data are representative of four independent experiments. See also Figure S2.
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cell types prompted us to evaluate whether type I IFNs induces
robust antiviral protection against certain viruses but not others.
To this end, we infected IFN-b-pretreated neurons and MEFs
with vesicular stomatitis virus (VSV) expressing G protein fused
with GFP (VSV-GFP) (Dalton and Rose, 2001) and assessed
the extent of viral infection by flow cytometry. In contrast to
HSV-1, IFN-b pretreatment effectively restricted VSV infection
in both neurons and MEFs (Figure S3B), suggesting that ISGs
that control VSV infection are sufficiently induced by IFN in
neurons. Collectively, these data indicate that type I IFN receptor
signaling leads to altered expression of ISGs in theDRGneurons,
leading to impaired control of some, but not all, viral pathogens.
Absence of Autophagy in Epithelial Cells Does Not
Impact HSV Mucosal Defense
Upon identification of differences in the type I IFN responses in
neurons versus mitotic cells, we wished to investigate the role
of autophagy in neuronal innate antiviral defense. Autophagy is
an antiviral defense mechanism that does not require cell death
for virus control. Autophagy has been shown to play a direct role
in controlling viral replication by engulfing cytosolic virions for
lysosomal degradation (Levine, 2005). We utilized a mouse
model of genital herpes infection to evaluate the contribution of
autophagy in epithelial cells and neurons. In this model, HSV-1
introduced to the vaginal canal undergoes a primary round of
replication in themucosal epithelial cells at the site of inoculation.
Subsequently, innervating neurons become infected, resulting in
neuropathogenesis and death in a certain percentage of hosts.
To determine the antiviral function of autophagy in epithelial
cells, we generated Atg5 flox/flox 3 Krt14-cre Tg (KC-Atg5 KO)
mice to specifically delete Atg5 within the keratinocytes (KC).
Selective deletion of Atg5 in epidermal keratinocytes at tran-
scriptional and functional levels was confirmed (Figures 4A–
4D). The level of Atg5 mRNA expression was significantly lower
in the keratinocytes isolated from the KC-Atg5 KO mice but
not in the liver cells (Figures 4A and 4C). In addition, measure-
ment of LC3-I and its autophagosome associated form (LC3-II)
in primary cells isolated from the KC-Atg5 KO mice by western
blot (Klionsky et al., 2008) revealed a selective defect in
LC3-II formation in the keratinocytes but not in the liver cells
(Figures 4B and 4D). Adult female KC-Atg5 KO mice and Atg5
flox/flox 3 Krt14-cre(–) littermates (WT) were intravaginally in-Cell Host & Mfected withWTHSV-1. We found no difference in viral replication
within the vaginal mucosa in the absence of autophagy in the
keratinocytes (Figure 4E). Furthermore, cytokine secretion in
the vaginal mucosa was indistinguishable between KC-Atg5
KO mice and WT counterparts (Figure S4). Collectively, these
results indicated that autophagy in epithelial cells does not
significantly contribute to local inflammatory response or anti-
viral defense in HSV-1 infection.
HSV encodes a virulence factor, ICP34.5, that inhibits auto-
phagy through binding to Beclin-1 and preventing de novo
autophagosome formation (Orvedahl et al., 2007). Therefore, it
was possible that a potential contribution of epithelial cell auto-
phagy to antiviral immunity was being masked by ICP34.5-
dependent inhibition of autophagy in wild-type mice. To address
this possibility, we intravaginally infected wild-type mice with
either a mutant HSV-1 in which the Beclin-1 binding domain of
ICP34.5 has been specifically deleted (bbd) or with the rescued
virus (bbdR) (Leib et al., 2009). Viral replication, peak viremia, and
viral clearance in the genital mucosa were indistinguishable after
infection with bbd and bbdR, indicating that viral replication in
the epithelial cells was independent of the ability of HSV to inhibit
autophagy (Figure 4E). Local cytokine production was also
similar between infection with bbd and bbdR, confirming our
previous observations that the absence of autophagy in the
vaginal epithelium does not significantly impact the innate or
adaptive immune cytokine responses (Figure S4). Collectively,
these data indicated that autophagy was not required for
HSV-1 control within the vaginal epithelium.
HSV Inhibition of Autophagy in Nonepithelial Cell Type
Is Required for HSV-Induced Mortality
Next, we examined whether autophagy in the context of nonepi-
thelial cells is required for control of HSV-1 infection. To this end,
we intravaginally infected KC-Atg5 KO mice and WT littermates
[Atg5 flox/flox Krt14-cre(–)] mice with either bbd or bbdR virus
and evaluated disease outcome. We found a striking difference
in pathology, weight loss, and survival between mice infected
with bbd and bbdR virus (Figures 4F–4H). Approximately 50%
of all mice infected with bbdR (WT HSV-1) developed advanced
clinical manifestations and ultimately succumbed to infection.
In contrast, mice infected with the bbd mutant HSV-1 were
completely resistant to viral induced pathology or mortality.
Importantly, differences in morbidity and mortality were entirelyicrobe 12, 334–345, September 13, 2012 ª2012 Elsevier Inc. 337
Figure 3. Type I Interferon Primes Mitotic
Cells, but Not Neurons, for Cell Death
(A) MEFs, and neurons were pretreated for 18 hr
with the indicated amount of IFN-b. All cells were
then transfected with Poly I:C (1.0 mg/ml) for 1 hr.
At the time points indicated, MEFs and neurons
were isolated, stained with trypan blue, and
counted by hematocytometer (top). MEFs and
neurons were isolated, stained with Annexin V
and 7-AAD, and analyzed by flow cytometry
(bottom). Data are representative of three inde-
pendent experiments.
(B) MEFs and neurons were treated with staur-
osporine and isolated, stained with trypan blue,
and counted by hematocytometer at the time
points indicated.
Error bars represent SEM. See also Figure S3.
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percentages of KC-Atg5 KO mice and WT mice succumbed to
infection by bbdR (Figures 4F–4H). Collectively, these data indi-
cated that autophagy was critical in controlling HSV-1 disease in
a nonepithelial cell type in vivo.
Attenuation of bbd Mutant HSV-1 Is Not Dependent on
Enhanced T Cell Responses
Autophagy has been shown to enhance MHC class II antigen
presentation of cytosolic viral antigens in professional antigen-
presenting cells (APCs) and in nonprofessional APCs such as
epithelial cells (Dengjel et al., 2005; Leib et al., 2009; Paludan
et al., 2005; Schmid et al., 2007). After corneal infection, bbd
mutant HSV-1 leads to enhanced CD4 T cell responses
compared to the bbdR virus (Leib et al., 2009). Thus, it was
possible that pathogenesis of the WT HSV-1 is due to impaired
activation of adaptive immune responses by infected APCs. To
evaluate this possibility, we examined CD4+ T cell responses in
the draining lymph node after infection with bbd and bbdR, as338 Cell Host & Microbe 12, 334–345, September 13, 2012 ª2012 Elsevier Inc.Th1 cells play a key role in viral control in
HSV-1 infected mice (Harandi et al.,
2001; Milligan et al., 1998). At 6 and
8 days after infection, lymph node
enlargement, total CD4+ T cell number,
and CD4+ T cell IFN-g production in
response to viral antigen stimulation was
comparable between mice infected with
bbd and bbdR (Figures 5A–5C). These
data indicated that viral inhibition of host
autophagy does not significantly alter
the generation of mucosal CD4+ T cell
responses. In addition, infection with
bbdor bbdRHSV-1 showed identical viral
replication in the vaginal mucosa of both
Cd4- (Figures 5D and 5E) and Cd8-
(Figures 5F and 5G) deficient mice. Infec-
tion of Cd8/mice with bbdR resulted in
mortality equivalent to infection of wild-
type mice, while no morbidity or mortality
was observed in infection with bbd. Simi-
larly, bbd infection of Cd4-deficient micedid not result in mortality or any clinical manifestations. In
contrast, infection of Cd4/ mice with bbdR resulted in 90%
mortality (Figure 5E), consistent with previous reports demon-
strating the critical role for CD4+ T cells in HSV control (Harandi
et al., 2001; Iijima et al., 2008; Milligan et al., 1998). These data
indicated that, unlike corneal infection (Leib et al., 2009), the
differences in disease outcome upon vaginal infection with bbd
and bbdR were not dependent on CD4 or CD8 T cell responses.
In addition to binding Beclin-1 and inhibiting autophagy,
ICP34.5 binds to TBK1 and blocks the induction of antiviral
genes (Verpooten et al., 2009). TBK-1 binding is mediated by
the region that partially overlaps with that deleted in the bbd
mutant. To evaluate whether bbd deletion in ICP34.5 results in
loss of blockade of type I IFN induction, we infected MEFs and
neurons with either bbd or bbdR and examined IFN-b expression
levels. As shown in Figure S5, we observed a comparable
increase in IFN-b expression levels in bbd-infected MEFs or
neurons over the bbdR-infected counterparts. These data
are consistent with a previous report showing that IRF3
Figure 4. Viral Inhibition of Autophagy in an Infected, Nonepithelial Cell Type Is Required for HSV-1-Induced Disease
(A–D) Keratinocytes and total liver were isolated from Atg5flox.floxKrt14cre+ (KO) and Atg5flox.floxKrt14cre– (WT) mice. Atg5mRNA expression relative to levels
in KO is shown for keratinocytes (A) and liver (C). Western blot analysis of LC3-I and LC3-II from isolated keratinocytes (B) and total liver (D) is shown. Loading
control (b-actin) for each sample is shown below. n > 2 for all genotypes, and data are representative of two independent experiments.
(E–H) Depo-provera-treated Atg5 flox/flox3 Krt14-cre Tg (KC-Atg5 KO) and Atg5 flox/flox Krt14cre(–) (WT) littermates were intravaginally infected with 5,000 pfu
of either HSV-1 bbd or the rescue virus bbdR. Vaginal washes were collected daily and viral titers were measured (E). Mice were weighed (F), clinically scored (G),
and monitored for survival (H) every 24 hr after infection. Error bars represent SEM of nR 12 mice per group.
**p% .001, ***p% .0005 mortality of bbdR-infected mice relative to bbd infection. Data are pooled from three independent experiments. See also Figure S4.
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(Leib et al., 2009). Therefore, these data argue that the avirulent
phenotype of the bbd HSV-1 mutant is unlikely to be explained
by the lack of TBK-1 inhibition. However, it is possible that bbd
mutation results in additional defects that could contribute to
the attenuation we observe in vivo.
Autophagy Is Required to Restrict Viral Replication
in the Peripheral Nervous System
Our data indicated that while autophagy was dispensable for
viral control in epithelial cells, it functioned in a critical capacityCell Host & Min another infected cell type. Given that HSV-infection is primarily
limited to mucosal epithelial cells and neurons (Iwasaki, 2003;
Parr et al., 1994; Parr and Parr, 2003), we hypothesized that
autophagy is critical in antiviral defense in neurons but not
epithelial cells. To test this hypothesis, we first examined the
ability of bbd and bbdR viruses to replicate in the DRG inner-
vating the vaginal mucosa in vivo. Wild-type C57BL/6 mice
were intravaginally infected with either bbd or bbdR HSV-1,
and innervating DRG were isolated at several time points after
infection. Infectious virus of both strains was detectable at
48 hr after infection, suggesting that viral entry to the PNSicrobe 12, 334–345, September 13, 2012 ª2012 Elsevier Inc. 339
Figure 5. Neuroattenuation of bbd Is Independent of T Cell Responses
(A–C) Depo-provera-treatedWT C57BL/6 mice were intravaginally infected with 20,000 pfu of HSV-1 bbd or the rescue mutant bbdR, and were analyzed on days
6 and 8 after infection. Total number of lymphocytes (A), and CD4+ T cells (B) from the iliac and lingual draining lymph nodes is depicted. Isolated CD4+ T cells
were cocultured with naive splenocytes in the presence of heat-inactivated HSV-1 (C). IFN-g secretion from CD4+ T cells was measured by ELISA.
(D–G)Cd4/ (dotted line),Cd8/ (dotted line), andWT control C57BL/6 mice were intravaginally infected with 2,000 pfu of the indicated strain of HSV-1. Vaginal
washes of Cd4/ (D) and Cd8/ (F) mice were collected daily and viral titers were measured in Vero cells. Cd4/ (E) and Cd8/ (G) mice were monitored for
survival every 24 hr after infection. Error bars represent SEM of nR 5 mice per group.
Data are pooled from four (A–C) or three (D–F) independent experiments. See also Figure S5.
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viral replication was markedly higher in mice infected with bbdR
at later time points, suggesting that autophagy within neurons
limits HSV-1 viral replication in the absence of viral evasion.
Next, we evaluated whether morbidity and mortality we
observed in bbdR-infected mice corresponded to an increase
in HSV-1 replication in the nervous tissue. First, we analyzed
the viral replication in the central nervous system at various
time points, and we found that neither bbdR nor bbd undergoes
significant replication in the brain stem or the spinal cord of the
infected animal (Figures 6B and 6C). Additionally, viral genome
copy number was comparable between bddR and bbd in
HSV-1 infected brainstem and spinal cord (Figures 6E and 6F).340 Cell Host & Microbe 12, 334–345, September 13, 2012 ª2012 ElIn contrast, both bbd and bbdR replicated in the DRG, and
bbdR-infected mice tended to have elevated viral copy numbers
in the DRG (Figures 6A and 6D). Next, we examined whether
HSV-1 infection leads to inflammation and pathology in the
PNS and CNS. Hematoxylin and eosin-stained sections of the
DRG, spinal cord, and brainstem from bbd- and bbdR-infected
mice at various time points after intravaginal infection were
analyzed in a blinded manner. Consistent with the minimal viral
invasion observed in the CNS, we detected minimal inflamma-
tion in the CNS even with a high viral challenge dose (Figure S6).
In contrast, the DRG from bbdR-infected, but not bbd-infected,
mice had signs of inflammatory infiltrate and tissue damage
(Figure S6). Collectively, these data indicate that mice infectedsevier Inc.
Figure 6. Autophagy Is Required to Restrict Neuronal HSV-1 Replication
Depo-provera treated wild-type C57BL/6 mice were infected with 2 3 104 pfu of the indicated strain of HSV-1. Dorsal root ganglia, spinal cord, and brainstem
were isolated at the time points indicated and homogenized. Viral titers were measured in Vero cells (A–C), and genome copy of isolated DNA was determined by
qPCR (D–F). Error bars represent SEM (A–C) of n > 5 and n > 4 (D–F). Gray dotted lines indicate the limit of detection. Data are pooled from three independent
experiments. *p < 0.05; ns, not significant. See also Figure S6.
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a neurologic disease primarily restricted to the PNS.
Autophagy and the Type I IFN Pathway Restrict Viral
Replication in Parallel in PNS Neurons
Our data demonstrated that an HSV-1mutant incapable of inhib-
iting host autophagy (bbd) replicates similarly as the WT HSV-1
(bbdR) at the mucosal site of infection but is significantly
impaired in replication in the PNS, thus implying that autophagy
in neurons is critical in HSV defense. However, it is possible that
the difference in host outcome we observed in infection with bbd
and bbdR infection results from cell types other than epithelial
cells or neurons. Therefore, to directly test the requirement for
autophagy within neurons, we crossed Atg5 flox/flox mice with
Nestin-cre Tgmice to conditionally delete autophagy in neurons.
Neuron-specific deletion of autophagy results in accumulation of
self-proteins and development of severe neurological impair-
ments beginning at 3 weeks of age (Hara et al., 2006; Komatsu
et al., 2006). In order to directly assess the requirement of auto-
phagy in antiviral defense and minimize complications involving
accumulation of host proteins, we isolated DRG neurons from
2.5-week-old Atg5 flox/flox 3 Nestin-cre Tg(+) (Neuron-Atg5
KO) and Atg5 flox/flox 3 Nestin-cre(–) (WT) littermate control
and infected them ex vivo. HSV-1 viral replication was markedly
increased in neurons in which autophagy had been conditionally
deleted, regardless of the viral genotype (Figure 7A). Notably,
Atg5-deficient neurons supported higher bbdR viral replication
than the WT neurons, implying that autophagy mediates rapidCell Host & Mantiviral defense within neurons even prior to the viral ICP34.5
gene expression. Importantly, Atg5-deficient neurons supported
replication of bbd and bbdR to similar extent, indicating that the
defect in bbd replication is restored in the absence of host auto-
phagy gene.
The interferon pathway and certain Atg genes, including Atg5,
have recently been shown to cooperate in innate antiviral
defense (Hwang et al., 2012). Specifically, this study demon-
strated that IFN-g blocks norovirus replication by recruiting Atg
proteins to inhibit the formation of replication complex. There-
fore, we wished to determine whether Atg5 and type I IFN path-
ways operate independently or cooperatively to restrict HSV-1
replication in neurons. To this end, we tested whether Atg5 is
required for IFNabR signaling and/or carrying out IFN-dependent
antiviral effector functions in neurons. In order to evaluate
whether Atg5 is required for IFNabR signaling, we examined
the expression levels of ISGs after treatment with IFN-b, with
or without HSV-1 infection. Because neurons are less responsive
to IFN-b (Figures 2, S2, and S3), we used a higher dose (1,000 U/
ml) for these experiments. We observed nearly identical ISG
mRNA levels in WT and Atg5-deficient cells induced by IFN-b
treatment alone (Figure 7B) or in combination with HSV-1 infec-
tion (Figure 7C). These data indicated that the IFN-abR signaling
in general or in the context of HSV-1 infection does not require
Atg5 in neurons.
Next, to test whether Atg5 is required for IFN-dependent anti-
viral defense, we examined HSV-1 replication inAtg5/ neurons
after a high dose of IFN-b treatment. If Atg5 is required foricrobe 12, 334–345, September 13, 2012 ª2012 Elsevier Inc. 341
Figure 7. Autophagy and Type I IFNs Restrict HSV-1 Replication in Neurons in Parallel
Primary neuronswere isolated fromAtg5 flox/flox3Nestin-cre Tg (Neuron Atg5 KO) andAtg5 flox/floxNestin-cre(–) (WT) littermates. Neuronswere infected at the
indicated MOI with either bbd or bbdR HSV-1, at MOI of 0.01 (A), or at MOI of 0.1 with or without treatment with 1,000 U/ml of IFN-b 18 hr prior to infection (D).
(A and D) Supernatants were collected at points indicated and viral titers were measured.
(B andC) RNA isolated from neurons treatedwith 1,000U/ml IFN-b alone (B) or followed byHSV-1 infection for additional 48 hr was used tomeasure expression of
indicated ISG by RT-qPCR.
Error bars represent SEM and data are representative of two to four independent experiments. Gray dotted lines indicate limit of detection. See also Figure S7.
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pected to protect Atg5/ neurons from HSV-1 infection.
However, our data demonstrated that IFN-b conferred signifi-
cant protection in Atg5/ neurons (Figure 7D). Of note, both
bbdR and bbd still replicated at higher levels in Atg5/ neurons
than in WT neurons even after engagement of full ISG responses
after IFN-b treatment, highlighting that autophagy provides addi-
tional antiviral defense in neurons. In contrast, in vitro replication
of bbd and bbdR was indistinguishable in WT or Atg5-deficient
MEFs, whereas type I IFN treatment was sufficient to prevent
viral replication in this cell type (Figure S7) (Alexander et al.,
2007). Thus, both IFN and autophagy work in parallel to confer
antiviral protection against HSV-1 in neurons, and ICP34.5
permits efficient HSV-1 replication by effectively countering
both of these neuronal restriction strategies.
DISCUSSION
Neuron death, engendered by either pathogen infection or lytic
immune responses, can have severe pathological repercussions
(Brot et al., 1997). Neurons employ alternative adaptive immune
strategies to minimize cell death during infection (Joly et al.,
1991; Levine et al., 1991). Here, we contribute to this paradigm
by presenting evidence that neurons have reduced type I IFN-
dependent innate responses and are heavily reliant on an alter-
native, prosurvival pathway for antiviral defense. Our results
provide experimental evidence for the hypothesis that auto-
phagy is a particularly suitable means of antiviral defense used
by neurons (Alexander and Leib, 2008; Orvedahl et al., 2007;
Orvedahl and Levine, 2008), by promoting both cell survival342 Cell Host & Microbe 12, 334–345, September 13, 2012 ª2012 Eland aiding in viral clearance. We found that HSV-1 infected
neurons produced significantly less endogenous type I IFNs
and entered a less effective anti-HSV-1 state in response
to type I IFN stimulation relative to primary mitotic cells. In
addition, neurons were resistant to type I IFN priming of cell
death upon detection of viral PAMPs. Consistent with these
observations, we found type I IFN induced a unique ISG expres-
sion pattern in neurons after IFN-b stimulation. In order to under-
stand how neurons might compensate for attenuation of this
key antiviral response pathway, we investigated the role of
alternative forms of host innate defense. We found that either
genetic ablation or viral inhibition of host autophagy resulted
in significantly higher levels of HSV-1 replication in neurons,
but not in mitotic cells in vitro and in vivo. Further, we demon-
strate that autophagy and type I IFNs operate in parallel
to defend against HSV-1 infection. Finally, our in vivo data
suggest that even in the presence of intact innate and adaptive
immune responses to the virus, neurons rely on cell intrinsic
autophagy-dependent antiviral effector mechanism to counter
HSV-1 infection.
Vertebrate antiviral defense mechanisms have evolved to
depend heavily on the type I IFN system. Our data suggest a
model in which the type I IFN-mediated viral control predomi-
nates over direct autophagic viral clearance in vertebrate
tissues that can be readily repopulated by stem cells. However,
in terminally differentiated, irreplaceable cell types such as
neurons, we propose that the reduction in IFN responsiveness
and cell death results in an enhanced dependency for nonlytic
antiviral defense mechanisms such as autophagy. In support
of this model, we find that type I IFN is less effective at blockingsevier Inc.
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cells. These findings complement previous reports demon-
strating neurons are resistant to certain adaptive, lytic immune
responses (Joly et al., 1991; Knickelbein et al., 2008) and are
less likely to undergo apoptosis after infection with HSV (Esaki
et al., 2010).
Previous studies have demonstrated that type I IFNs are effec-
tive in controlling viral replication in neurons in vivo and in vitro,
particularly in the central nervous system (Paul et al., 2007).
For example, type I IFN pathway in neurons is critical in antiviral
defense against HSV (Carr et al., 2003; Leib et al., 1999;Menach-
ery et al., 2010), as well as numerous other neurotropic viruses
(Iannacone et al., 2010; Lenschow et al., 2007; Samuel and
Diamond, 2005). However, our data suggest that type I IFN
responses in PNS neurons are distinct from those in other cell
types, such that they limit robust signaling capable of priming
large-scale neuron death during viral infection, particularly in
postmitotic peripheral neurons. These findings are in agreement
with a recent study demonstrating that cortical neurons have
significantly lower basal ISG expression versus macrophages
(Daffis et al., 2007) and that previously observed type I IFN-
dependent protection against certain neurotropic viruses may
be dependent on responses within astrocytes and other resident
mitotic cells of the nervous system (Reinert et al., 2012). We
speculate that such a mechanism serves as a ‘‘failsafe’’ for
type I IFN signaling in order to avoid widespread death of
neurons upon detection of viral infection. However, such a safety
mechanism comes at a significant cost—reduced innate protec-
tion against certain neurotropic viruses.
We sought to determine how neurons might offset this ‘‘cost’’
in antiviral defense. We found that neurons rely on autophagy to
limit HSV-1 replication. Even when ISGs are fully turned on by
high levels of type I IFN, Atg5-dependent process confers addi-
tional antiviral defense in neurons. Intriguingly, the current
evidence for the role of autophagy in direct antiviral defense in
vertebrate in vivo (Orvedahl et al., 2007; Orvedahl et al., 2010)
has been limited to nervous system infections of neurotropic
viruses. In addition, other neurotropic viruses are known to inter-
fere with autophagy in vitro (Chaumorcel et al., 2008). Based on
our current study, we hypothesize that these findings reflect
a unique neuronal requirement of autophagy in direct antiviral
defense. However, it is important to note that viruses that are
not known to be primarily neurotropic, including HIV-1 (Zhou
and Spector, 2008), SIV (Alirezaei et al., 2008), and gamma-
herpesviruses (Ku et al., 2008; Pattingre et al., 2005), also
encode factors that specifically interfere with autophagy. Conse-
quences of autophagy inhibition by these viruses may be to
inhibit innate and adaptive immune responses (Blanchet et al.,
2010).
Our study demonstrates that the vertebrate immune system
may utilize distinct innate antiviral strategies that are suitable
for the physiology of the infected cell types. These findings
not only reinforce the concept that vaccine and therapeutic
treatment of viral infections should be tailored to maximize
cell type-appropriate defense mechanisms, but also pro-
vide important implications for treatment of HSV infections.
Specifically, pharmacological inducers of autophagy might be
beneficial in limiting replication of HSV-1, and possibly HSV-
2, in neurons in both acute and chronic infections. Since ourCell Host & Mdata indicated that PNS neurons have the capacity to limit
virus infection through autophagy even in the face of
ICP34.5-intact wild-type HSV-1 infection, enhancement of
autophagic flux in neurons may hold promise in treating clinical
infections in humans. In addition, similar approaches might be
beneficial in treatment of other neurotropic or postmitotic viral
infections.EXPERIMENTAL PROCEDURES
Animals
Six-week-old female C57BL/6 mice were obtained from the National Cancer
Institute (Frederick, MD). Atg5 flox/flox (Hara et al., 2006) (a kind gift of
Dr. Noboru Mizushima, Tokyo Medical and Dental University, Japan), Krt14-
Cre Tg, Nestin-Cre Tg, Cd4/, and Cd8/ (The Jackson Laboratory) mice
were bred in the Yale animal facility. All procedures performed in this study
complied with federal guidelines and institutional policies set by Yale Animal
Care and Use Committee.
In Vivo Infections
HSV-1 bbd and HSV-1 bbdR are previously described (Leib et al., 2009). HSV-
1-GFP was a kind gift from Drs. P. Desai and S. Person (Johns Hopkins
University, MD). HSV-1 wasmaintained, propagated, and tittered in Vero cells.
Intravaginal HSV-1 infection was performed as described previously (Lee et al.,
2010). In brief, HSV-1 in 10 ml PBS was introduced into the vaginal canal of
Depo-provera-treated female mice. After infection, vaginal washes were
collected daily in 50 ml PBS. Mice were weighed and clinically scored every
24 hr after infection. Clinical score was assigned based on the scale utilized
by Morrison et al. (1998). All mice were euthanized prior to reaching moribund
state due to humane concerns. Viral titer from DRG was determined by
removal of the lumbar and sacral DRG from intravaginally infected mice.
Isolated DRG was homogenized by rotor-stator and sonicated to release
membrane bound virus.
Primary Neuron Isolation and Culture
DRG neurons were isolated from either adult (6- to 8-week-old) C57BL/6 or
juvenile (2- to 3-week-old) Atg5 flox/flox Nestin-Cre Tg mice and Atg5 flox/
flox Nestin-Cre(–) littermate controls (age and sex matched), as described
previously (Malin et al., 2007). In brief, DRG were removed from the spinal
column, gently dissected by papain (Worthington), collagenase II (Worthing-
ton), and dispase II (Roche), and gently triturated to a single-cell suspension.
Cells were then adhered to laminin (Sigma)/poly-D-lysine (Sigma) coated
coverslips and cultured in Neurobasal media (GIBCO) supplemented with
B-27 supplement (GIBCO), L-glutamine (GIBCO), and neurite growth factor
2.5S (Millipore). The mitotic inhibitor 5-fluorodeoxyuridine (MP Biomedicals)
and uridine (MP Biomedicals) were added to prevent outgrowth of mitotic
cells.
Poly I:C Stimulation of Cells
MEFs, neurons, and keratinocytes were stimulated with 1.0 mg/ml Poly I:C or
Poly I:C Rhodamine (Invivogen) complexed to Lipofectamine 2000 (Invitrogen).
All cells were transfected for 1 hr in Optimem media (GIBCO). Where noted,
cells were stimulated with 10.0 mg/ml staurosporine. At the indicated time
points, adherent and detached cells were isolated by TrypLE (GIBCO). The
number of live cells was determined by trypan blue exclusion assay. Cell death
was evaluated by staining of all cells with 7-AAD and PE-Annexin V according
to the manufacturer’s instructions of the PE Annexin V Apoptosis kit (BD
PharMingen) followed by flow cytometry analysis.
Statistics
Statistical analysis of survival curves was performed with the log rank (Mantel-
Cox) test. Graphs containing two data sets were analyzed by unpaired t tests,
while those containing more than two data sets were analyzed by one-way
ANOVA followed by Tukey test, unless otherwise noted. All statistical analyses
were performed in Graphpad Prism v5.0.icrobe 12, 334–345, September 13, 2012 ª2012 Elsevier Inc. 343
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